コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ated sensing of the 5'-epsilon region of HBV pregenomic RNA.
2 otein and the DNA polymerase and also is the pregenomic RNA.
3 mmediately prior to the encapsidation of the pregenomic RNA.
4 d the phenotype of enhanced encapsidation of pregenomic RNA.
5 ar relaxed circular double-stranded DNA, and pregenomic RNA.
6 number of nucleotides from the 5' end of the pregenomic RNA.
7 most likely binding of the polymerase to the pregenomic RNA.
8 reverse transcriptase ("polymerase") and the pregenomic RNA.
9 prevent the proper encapsidation of the HBV pregenomic RNA.
10 riptase binds cotranslationally to the viral pregenomic RNA.
11 3 kb of full-length in vitro-transcribed HBV pregenomic RNA.
12 tide and an RNA segment, epsilon, present on pregenomic RNA.
13 ly repressed synthesis of both the pre-C and pregenomic RNAs.
14 This clone, named HDE1, expresses a chimeric pregenomic RNA, a chimeric polymerase (P) protein, and a
15 ends upon cis-acting elements present in its pregenomic RNA and a trans-acting protein (P6) which is
16 in dimer bound and encapsidated both the HBV pregenomic RNA and heterologous RNA with high levels of
17 apy, as are lower intrahepatic levels of HBV pregenomic RNA and pre-activated host immune responses.
18 rocess leading to (1) the packaging of viral pregenomic RNA and reverse transcriptase into nucleocaps
19 es support transcription of the 3.5-kb viral pregenomic RNA and subsequent viral DNA synthesis by rev
21 significantly higher levels of synthesis of pregenomic RNA and viral DNA than wild-type HBV in coexp
22 gonized each other's effects on synthesis of pregenomic RNA and viral DNA when they were co-overexpre
23 ntial target sites were found within the HBV pregenomic RNA, and 17 sites conserved in all four subty
24 mediate DNA, covalently closed circular DNA, pregenomic RNA, and the percentage of WHV core antigen-p
26 first 74 nucleotides of the 7,954-nucleotide pregenomic RNA appears to be essential for P6 to transac
27 taining the viral single-stranded DNA or the pregenomic RNA are incompetent for either envelopment or
28 nerated by the final RNase H cleavage of the pregenomic RNA at an 11 nt sequence called DR1 during th
29 site lesions produced a modest reduction of pregenomic RNA but had no impact on viral DNA synthesis.
30 re-than-10-fold increase in synthesis of the pregenomic RNA but to only a 2- to 3-fold increase in sy
31 hepadnaviruses is reverse transcribed from a pregenomic RNA by a viral polymerase (Pol) harboring bot
32 ignal (the packaging signal, epsilon) on the pregenomic RNA by the viral reverse transcriptase (RT).
34 tis B virus (HBV) replication by eliminating pregenomic RNA containing viral capsids from the hepatoc
35 IFN-alpha/beta or IFN-gamma, which eliminate pregenomic RNA-containing capsids from the cells as they
37 HNF4 and TR2) or activated synthesis of the pregenomic RNA (e.g., PPARgamma-RXRalpha), other members
38 isense RNA was found to reduce the amount of pregenomic RNA encapsidated into core particles as a mol
39 Here we study the thermodynamic basis of the pregenomic RNA encapsidation in human Hepatitis B virus
40 ng the F501L substitution showed a decreased pregenomic RNA encapsidation level, suggesting that the
45 cells, lesions in the HNF-1 site inactivated pregenomic RNA expression and viral reverse transcriptio
46 volves the transcription of the 3.5-kb viral pregenomic RNA, followed by its reverse transcription in
48 II is primarily devoted to the regulation of pregenomic RNA in WHV, (ii) HNF-1 is essential for EnII
53 ts indicated that synthesis of the pre-C and pregenomic RNAs is directed by two distinct promoters an
54 terized by a more efficient encapsidation of pregenomic RNA leading to highly enhanced replication.
56 iRNA, Northern blot analysis showed that HBV pregenomic RNA levels were decreased by 72%, and levels
57 ld repression of synthesis of both pre-C and pregenomic RNAs mediated through either NRRE(preC) or NR
59 The epsilon stem-loop at the 5' end of the pregenomic RNA of the hepatitis B viruses is both the pr
62 ously, was performed to measure encapsidated pregenomic RNA (pgRNA) and minus-strand DNA synthesized
63 The capsid protein (Cp) packages the viral pregenomic RNA (pgRNA) and polymerase to form the HBV co
64 plication by decreasing the transcription of pregenomic RNA (pgRNA) and subgenomic RNA from the HBV c
65 otein specifically encapsidates a complex of pregenomic RNA (pgRNA) and viral polymerase; it has been
66 V) capsid proteins (Cps) assemble around the pregenomic RNA (pgRNA) and viral reverse transcriptase (
67 ignal (the packaging signal, epsilon) on the pregenomic RNA (pgRNA) by the viral reverse transcriptas
68 NA genome through reverse transcription of a pregenomic RNA (pgRNA) by using a multifunctional polyme
69 NA genome through reverse transcription of a pregenomic RNA (pgRNA) by using a multifunctional polyme
70 terminal regions of hepatitis B virus (HBV) pregenomic RNA (pgRNA) harbors sites governing many esse
73 s B virus (HBV) begins with packaging of the pregenomic RNA (pgRNA) into immature nucleocapsids (NC),
74 o identify other cis-acting sequences on the pregenomic RNA (pgRNA) involved in the synthesis of minu
77 T-epsilon interaction with those for in vivo pregenomic RNA (pgRNA) packaging clearly indicated that
79 ther analysis showed that HNF6 reduced viral pregenomic RNA (pgRNA) posttranscriptionally via acceler
80 nt in multiple copies in and adjacent to the pregenomic RNA (pgRNA) terminal redundancy, that were sp
83 ere we show that the pool of cytoplasmic HBV pregenomic RNA (pgRNA)-containing capsids is reduced 10-
84 ds dose dependently inhibit the formation of pregenomic RNA (pgRNA)-containing nucleocapsids of HBV b
93 r II (EnII) is located upstream of the major pregenomic RNA promoter and is thought to play an import
94 ages corresponding to encapsidation of viral pregenomic RNA, reverse transcription, and restriction t
98 ective ligands led to a fourfold increase in pregenomic RNA synthesis and a four- to fivefold increas
99 heterodimer support hepatitis B virus (HBV) pregenomic RNA synthesis and viral replication in nonhep
101 r receptors are a primary determinant of HBV pregenomic RNA synthesis and, hence, viral replication.
103 lication can occur in nonhepatoma cells when pregenomic RNA synthesis from viral DNA is activated by
104 vations indicate that HBV transcription, and pregenomic RNA synthesis in particular, is regulated by
106 plication in nonhepatic cells by controlling pregenomic RNA synthesis, indicating these liver-enriche
107 ignal (the packaging signal, epsilon) on the pregenomic RNA template by the viral reverse transcripta
108 he RT and an RNA signal located on the viral pregenomic RNA, termed epsilon, and is initiated through
109 m position on a bicistronic mRNA, called the pregenomic RNA, through a poorly characterized ribosomal
111 ed mutations resulted in a minor increase of pregenomic RNA transcription (two- to threefold) and a m
113 In contrast, HNF4 supports higher levels of pregenomic RNA transcription from the variant than from
114 alpha heterodimers support higher levels of pregenomic RNA transcription from the wild-type than fro
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。